Pathophysiology of and clinical significance of polyunsaturated fatty acids n-3 family;Patofyziologie a klinický význam vícenenasycený ch mastných kyselin řady n-3

Casopis Lekaru Ceskych

Volumn 144, Issue SUPPL. 1, 2005, Pages 6-18

  Žák, Aleš ^a,b   Tvrzicka E ^a   Zeman, M ^a   Vecka, M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b U Nemocnice 2   (Czech Republic)

Author keywords

Cardiovascular diseases; Cell membranes; Diabetes mellitus; Dyslipidemia; Eicosanoids; Gene expression; Hyperlipidemia; Metabolic syndrome; Phospholipids; Polyunsaturated fatty acids of n 3 family

Indexed keywords

MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ANTIARRHYTHMIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL MEMBRANE; CELL METABOLISM; CHLOROPLAST; CHRONIC INFLAMMATION; DIABETES MELLITUS; DIETARY INTAKE; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; FAT INTAKE; GENE EXPRESSION; GENE PROBE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MENTAL DISEASE; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SEA FOOD; SUDDEN DEATH; TUMOR;

EID: 18744386442     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Bang, H. O., Dyerberg, J., Hjorne, N.: The composition of food consumed by greenlandic Eskimos. Acta Med. Scand., 1976, 200, s. 69-73.
2. Southern California/RAND Evidence based Practice Center, LA, CA: Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on the inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. AHRQ Publication No. 04-E012-2, 339 s.
3. Peifer, J. J., Lundberg, W. O., Ishio, S., Warmanen, E.: Studies of the distribution of lipids in hypercholesterolemic rats 3. Changes in hypercholesterolemia and tissue fatty acids induced by dietary fats and marine oil fractions. Arch. Biochem. Biophys., 1965, 110, s. 270-283.
4. Dyerberg, J.: Linolenate-derived polyunsaturated fatty acids and prevention of atherosclerosis. Nutr. Rev., 1986, 44, s. 125-134.
5. th Edition, Amsterdam, Elsevier, 2002, 607 s.
6. Brenner, R. R.: Factors influencing fatty acid chain elongation and desaturation. In: Vergroesen, A. J., Crawford, M. The role of fats in human nutrition. London, Academic Press, 1989, s. 45-79.
7. Brenna, T. J.: Efficiency of conversion of α-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin. Nutr. Metab. Care, 2002, 5, s. 127-132.
8. Burdge, G.: α-Linolenic acid metabolism in men and women: nutritional and biological implication. Curr. Opin. Clin. Nutr. Metab. Care, 2004, 7, s. 137-144.
9. Kinsella, J. E., Broughton, S., Whelan, J. W.: Dietary unsaturated fatty acids: interactions and possible needs in relation to eicosanoid synthesis. J. Nutr. Biochem., 1990, 1, s. 123-141.
10. Calder, P. C.: N-3 Polyunsaturated fatty acids, inflammation: from molecular biology to the clinic. Lipids, 2003, 38, s. 343-352.
11. Crawford, M. A., Doyle, W., Williams, G., Drury, P. J.: The role of fats and EFAs for energy an cell structures in the growth of fetus and neonate. In: Vergroesen, A. J., Crawford, M. The role of fats in human nutrition. London, Academic Press, 1989, s. 82-116.
12. Ginsberg, B. H., Chaterjee, M., Yorek, M. A.: Increased membrane fluidity is associated with greatest sensitivity to insulin. Diabetes, 1987, 36 (Suppl.), s. 51A.
13. Yorek, M., Leeney, E., Dunlap, J., Ginsberg, B.: Effect of fatty acid composition on insulin and IGF-1 binding in retinoblastoma cells. Invest. Ophthalmol. Vis. Sci., 1989, 30, s. 2087-2092.
14. Rustan, A. C., Nenseter, M. S., Dreon, A. C.: Omega-3 and omega-6 fatty acids in the insulin resistance syndrome. Ann. New York Acad. Sci., 1997, 827, s. 310-326.
15. Rogers, S., James, K. S., Butland, B. K. et al.: Effects of fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. Atherosclerosis, 1987, 63, s. 137-143.
16. Leaf, A., Kang, J. X.: Dietary n-3 fatty acids in the prevention of lethal cardiac arrhytmias. Curr. Opin Lipidol., 1997, 8, s. 4-6.
17. Staels, B.: The PPAR system and regulation of lipoprotein metabolism. In: Betteridge, D. J.: Lipids and vascular disease. Current Issues, London, Martin Dunitz, 2000, s. 27-37.
18. Schoonjans, K., Martin, G., Staels, B., Auwerx, J.: Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr. Opin. Lipidol., 1997, 8, s. 159-166.
19. Jump, D. B.: Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr. Opin. Lipidol., 2002, 13, s. 155-164.
20. Lapillone, A., Clarke, S. D., Herd, W. C.: Polyunsaturated fatty acids and gene expression. Curr. Opin. Clin. Nutr. Metab. Care, 2004, 7, s. 151-156.
21. Clarke, S. D.: The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol., 2004, 15, s. 13-18.
22. Hughes, D. A., Pinder, A. C., Piper, Z. et al.: Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am. J. Clin. Nutr., 1996, 63, s. 267-272.
23. Yazu, K., Yamamoto, Y., Ukegawa, K., Niki, E.: Mechanism of lower oxidizability of eicosapentaenoate than linoleate in aqueous micelles. Lipids, 1996, 31, s. 337-340.
24. Yeh, S. L., Chang, K. Y., Huang, P. C., Chen, W. J.: Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition, 1997, 13, s. 32-36.
25. Holman, R. T., Johnson, S. B., Hatch, T. E.: A case of human linolenic acid deficiency involving neurological abnormalities. Am. J. Clin. Nutr., 1982, 35, s. 617-623.
26. Harper, C. R., Jacobson, T. A.: Beyond the Mediterranean Diet: The role of omega-3 fatty acids in the prevention of coronary heart disease. Prev. Cardiol., 2003, 6, s. 136-142.
27. Marckmann, P., Gronbaek, M.: Fish consumption and coronary heart disease mortality. A systematic review of prospective cohort studies. Eur. J. Clin. Nutr., 1999, 53, s. 585-590.
28. Eritsland, J., Arnesen, H., Seljeflot, I., Hostmark, A. T.: Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease. Am. J. Clin. Nutr., 1995, 61, s. 831-836.
29. Leaf, A., Jorgensen, M. B., Jacobs, A. K. et al.: Do fish oil prevent restenosis after coronary angioplasty? Circulation, 1994, 90, s. 2248-2257.
30. Burr, M. L., Fehily, A. M. I., Gilbert, J. F. et al.: Effects of changes in fat, fish, and fibre intake on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet, 1989, II, s. 757-761.
31. Lorgeril, de M., Salen, P., Martin, J. L. et al.: Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation, 1999, 99, s. 779-785.
32. Singh, R. B., Niaz, M. A., Sarma, J. P. et al.: Randomized, double blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian Experiment of Infarct Survial-4. Cardiovasc. Drugs Ther., 1997, 11, s. 485-491.
33. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet, 1999, 354, s. 447-455.
34. Geelen, A., Brouwer, I. A., Zock, P. L., Katan, M. B.: Antiarrhythmic effects of n-3 fatty acids: evidence from human studies. Curr. Opin. Lipidol., 2004, 15, s. 25-30.
35. Schmidt, E. B., Christensen, J. H.: Long-chain n-3 polyunsaturated fatty acids and coronary heart diseae. Curr. Opin. Clin Nutr. Metab. Care, 2000, 3, s. 109-115.
36. Harris, W. S., Park, Y., Isley, W. L.: Cardiovascular disease and long-chain omega-3 fatty acids. Curr. Opin. Lipidol., 2003, 14, s. 9-14.
37. Suzukawa, M., Abbey, M., Howe, P. R. C., Nestel, P. J.: Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J. Lipid Res., 1995, 36, s. 473-484.
38. Duriez, P., Berthezene, F., Fruchart, J. C.: Effect of fish oil (MAXEPA) on atherogenic lipoprotein particles defined by apolipoprotein composition (LpE:B, LpC-III:B) in patients with mixed hyperlipidemia. Abstracts of the 11th International Symposium on Atherosclerosis - Paris, 5-9 October 1997. Atherosclerosis, 1997, 134, s. 55.
39. Griffin, B. A., Fielding, B. A.: Postprandial lipid handling. Curr. Opin. Clin. Nutr. Metab. Care, 2001, 4, s. 93-98.
40. Nelson, G. J., Schmidt, P. C., Bartolini, G. L. et al.: The effect of dietary docosahexaenoic acid on plasma lipoproteins and tissue fatty acid composition in humans. Lipids, 1997, 32, s. 1137-1146.
41. Luo, J., Rizkalla, S. W., Vidal, H. et al.: Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Diabetes Care, 1998, 21, s. 717-724.
42. Benner, K. G., Sasaki, A., Gowen, D. R. et al.: The differential effects of eicosapentaenoic acid and oleic acid on lipid synthesis and VLDL secretion in rabbit hepatocytes. Lipids, 1990, 25, s. 534-540.
43. Feingold, K. R., Soued, M., Adi, S. et al.: Tumor necrosis factor increased hepatic very-low-density lipoprotein production and increased serum triglyceride levels in diabetic rats. Diabetes, 1990, 39, s. 1569-1574.
44. Zechner, R.: The tissue-specific expression of lipoprotein lipase: implications for energy and lipoprotein metabolism. Curr. Opin. Lipidol., 1997, 8, s. 77-88.
45. Feskens, E. J., Bowles, C. H., Kromhout, D.: Inverse association between fish intake and risk of glucose intolerance in normoglycemic elderly men and women. Diabetes Care, 1991, 14, s. 935-941.
46. Feskens, E. J., Virtanen, S. M., Rasanen, L. et al.: Dietary factors determining diabetes and impaired glucose tolerance. A 20 year follow up of Finnish and Dutch Cohorts in Sevens Countries Study. Diabetes Care, 1995, 18, s. 1104-1112.
47. Salmeron, J., Hu, F. B., Manson, J. E. et al.: Dietary fat intake and risk of type 2 diabetes in women. Am. J. Clin. Nutr., 2001, 73, s. 1019-1026.
48. Friedberg, C. E., Nanesen, M. J. F. M., Heine, R. J. et al.: Fish oil and glycemic control in diabetes: a meta-analysis. Diabetes Care, 1998, 21, s. 494-500.
49. Montori, V. M., Farmer, A., Wollan, P. C. et al: Fish oil supplementation in type 2 v diabetes: a quantitative review: Diabetes Care, 2000, 23, s. 1407-1415.
50. Rivellesse, A. A., Lilli, S.: Duality of dietary fatty acids, insulin sensitivity and type 2 diabetes. Biomed. Pharmacother, 2003, 57, s. 84-87.
51. Kopecký, J., Flachs, P.: Tkáňový metabolismus a obezita. In: Hainer, V. Základy klinické obezitologie. Praha, Grada - Avicenum, 2004, s. 121-152.
52. Storlien, L. H., Pan, D. A., Kriketos, A. D. et al.: Skeletal muscle membrane lipids and insulin resistance. Lipids, 1996, 31 (Suppl.), s. S261-S265.
53. Hotamisligil, G. S., Spiegelman, B. M.: Tumor necrosis factor α: A key component of the obesity-diabetes link. Diabetes, 1994, 43, s. 1271-1278.
54. Takahashi, Y., Ide, T.: Effects of dietary fats differing in degree of unsaturation on gene expression in rat adipose tissue. Ann. Nutr. Metab., 1999, 43, s. 86-97.
55. Oberkofler, H., Liu, Y. M., Esterbauer, H. et al.: Uncoupling protein-2 gene: reduced mRNA expression in intraperitoneal adipose tissue of obese humans. Diabetologia, 1998, 41, s. 940-946.
56. Seo, T., Blanek, W. S., Deckelbaum, R. J.: Omega-3 fatty acids: molecular approaches to optimal biological outcomes. Curr. Opin. Lipidol., 2005, 16, s. 11-18.
57. Crawford, M. A., Costeloe, K., Ghebremeskel, K. et al.: Are deficits of arachidonic and docosahexaenoic acids responsible for the neural and vascular complications of pre-term babies? Am. J. Clin. Nutr., 1997, 66 (Suppl.), s. 1032S-1041S.
58. Hibbeln, J. R., Salem, N. Jr.: Risks of cholesterol-lowering therapies. Biol. Psychiatry, 1996 40, s. 686-687.
59. Hibbeln, J. R., Salem, N. Jr.: Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am. J. Clin. Nutr., 1995, 62, s. 1-9.
60. Simopoulos, A. P.: Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr., 1991, 54, s. 438-463.
61. Vergroesen, A. J.: Essential fatty acids, biomembranes, and eicosanoid metabolism. In Vergroesen, A.J., Crawford, M.: The role of fats in human nutrition. London, Academic Press, 1989, s. 17-36.
62. Kremer, J. M.: Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids. Lipids, 1996, 31 (Suppl.), s. S243-S247.
63. Steinhardt, H. A., Greenberg, G. R.: Nutrition in inflammatory bowel disease. Curr. Opin. Gastroenterol., 1997, 13, s. 140-145.
64. Dunstan, J., Mori, T. A., Barden, A. et al.: Fish oil supplementation in pregnancy modifies neonatal alergen-specific immune response and clinical outcomes in infants at high risk of atopy: a randomised controlled trial. J. Allergy Clin. Immunol., 2003, 112, s. 1178-1184.
65. Mihrshahi, S., Peat, J. K., Marks, G. B. et al.: Childhood Asthma Prevention Study: Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J. Allergy Clin. Immunol., 2003, 111, s. 162-168.
66. Závada, J.: Syndrom multiorgánové dysfunkce. Praha, Grada-Avicenum, 2001, 254 s.
67. Schnell-Kretschmer, H., Hauenschild, A., Hardt, P. et al.: Therapy of severe hypertriglyceridemia with a MCT and omega-3 rich formula diet. In: XIII Internat. Symposium on "Drug Affecting Lipid Metabolism". Florence, May 30 - June 3, 1998. Abstract Book, s. 23.
68. OMACOR: Summary of Product Characteristics, Marketing Authorisation No. PL 15905/0001, May 2004. Public Health Service, Food and Drug Administration, NDA 21-654.
69. Martinez, M.: The fundamentals and practice of docosahexaenoic acid therapy in peroxisomal disorders. Curr. Opin. Clin. Nutr. Metab. Care, 2000, 3, s. 101-108.
70. Gadek, J. E., DeMichele, S. J., Karlslad, M. D. et al.: Effect of enteral feeding with eicosapentaenoic acid, γ-linolenic acid and antioxidants in patients with acute respiratory distress syndrome. Crit. Care, 1999, 27, s. 1409-1420.
71. Kenler, A. S., Swails, W. S., Driscoll, D. S. et al.: Early enteral feeding in postsurgical cancer patients. Fish Oil Structured Lipid Based polymeric Formula Versus a Standard Polymeric Formula. Ann. Surg., 1996, 223, s. 316-333.
72. Langans, W.: Peripheral mechanisms involved with catabolism. Curr. Opin. Clin. Nutr. Metab. Care, 2002, 5, s. 419-426.